幽门螺杆菌感染的治疗：过去与未来。 - Suppr

Treatment of Helicobacter pylori infection: the past and the future.

作者信息

Gisbert Javier P, Pajares José María

机构信息

Department of Gastroenterology, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Playa de Mojácar 29, Madrid, Spain.

出版信息

Eur J Intern Med. 2010 Oct;21(5):357-9. doi: 10.1016/j.ejim.2010.07.009. Epub 2010 Aug 1.

DOI:10.1016/j.ejim.2010.07.009

PMID:20816583

Abstract

摘要

相似文献

Treatment of Helicobacter pylori infection: the past and the future.

Eur J Intern Med. 2010 Oct;21(5):357-9. doi: 10.1016/j.ejim.2010.07.009. Epub 2010 Aug 1.

Levofloxacin in first-line treatment of Helicobacter pylori infection.

Helicobacter. 2007 Aug;12(4):364-5. doi: 10.1111/j.1523-5378.2007.00517.x.

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

Gut. 2010 May;59(5):572-8. doi: 10.1136/gut.2009.198309.

Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.

Eur J Intern Med. 2010 Aug;21(4):310-4. doi: 10.1016/j.ejim.2010.05.011. Epub 2010 Jun 16.

On the efficacy of macrolide-based therapy for Helicobacter pylori infection.

Panminerva Med. 2009 Mar;51(1):51; author reply 51-2.

Efficacy of clarithromycin in eradicating Helicobacter pylori.

J Gastroenterol. 1996 Nov;31 Suppl 9:53-5.

Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.

Helicobacter. 2007 Aug;12(4):359-63. doi: 10.1111/j.1523-5378.2007.00507.x.

Clarithromycin for treatment of Helicobacter pylori infections.

Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S55-8.

Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.

Aliment Pharmacol Ther. 2010 May;31(10):1077-84. doi: 10.1111/j.1365-2036.2010.04274.x. Epub 2010 Feb 20.

The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1315-21. doi: 10.1111/j.1365-2036.2004.01959.x.

引用本文的文献

A Comprehensive Review of Xanthan Gum-Based Oral Drug Delivery Systems.

Int J Mol Sci. 2024 Sep 21;25(18):10143. doi: 10.3390/ijms251810143.

A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against .

Antibiotics (Basel). 2022 Nov 11;11(11):1605. doi: 10.3390/antibiotics11111605.

Efficacy of levofloxacin, omeprazole, nitazoxanide, and doxycycline (LOAD) regimen compared with standard triple therapy to eradicate infection: a prospective randomized study from a tertiary hospital in India.

Gastroenterol Hepatol Bed Bench. 2021 Fall;14(4):342-348.

Safety and Efficacy of Nitazoxanide-Based Regimen for the Eradication of Infection: A Systematic Review and Meta-Analysis.

Gastroenterology Res. 2020 Dec;13(6):260-268. doi: 10.14740/gr1342. Epub 2020 Dec 23.

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.

Medicine (Baltimore). 2017 Feb;96(7):e5859. doi: 10.1097/MD.0000000000005859.

Effect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori.

Mol Ther Nucleic Acids. 2015 Dec 8;4(12):e269. doi: 10.1038/mtna.2015.46.

Production of specific IgY Helicobacter pylori recombinant OipA protein and assessment of its inhibitory effects towards attachment of H. pylori to AGS cell line.

Clin Exp Vaccine Res. 2015 Jul;4(2):177-83. doi: 10.7774/cevr.2015.4.2.177. Epub 2015 Jul 29.

Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.

Saudi Pharm J. 2014 Dec;22(6):570-9. doi: 10.1016/j.jsps.2014.02.009. Epub 2014 Mar 6.

Anti-Helicobacter pylori activity and Structure-Activity Relationship study of 2-Alkylthio-5-(nitroaryl)-1,3,4-thiadiazole Derivatives.

Iran J Pharm Res. 2013 Summer;12(3):281-7.

NMR study on small proteins from Helicobacter pylori for antibiotic target discovery: a review.

Molecules. 2013 Oct 30;18(11):13410-24. doi: 10.3390/molecules181113410.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treatment of Helicobacter pylori infection: the past and the future.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献